The primary outcome was the recurrence of AKI at 12 weeks. The secondary outcomes were the ability to re-introduction of beta-blockers and diuretics within 12 weeks. Results The two groups were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results